glp-1 and bowel obstruction Semaglutide-Induced Small Pseudo-Obstruction Ileitis in a Patient With Type 2 Diabetes: A Case Report GLP-1 Receptor Agonists in Diabetes

Mean age was 59 years, 53.7% were men, 64.7% earned less than 18,000/year, 71.2% had hypertension, 43.1% had anxiety, 36.0% had sleep disorders and 23.7% had registered tobacco use (Table 1)

Finerenone in heart failure with mildly reduced or preserved ejection fraction

Wchentliche Verabreichung (langwirksame GLP-1-RA): Albiglutid (Eperzan, ausser Handel) Dulaglutid (Trulicity) Exenatid (Bydureon, ausser Handel) Semaglutid subkutan (Ozempic) Tirzepatid (Mounjaro) bindet zustzlich an den GIP-Rezeptor GLP-1-Rezeptor-Agonisten werden auch mit Insulinen fix kombiniert, siehe unter IDegLira (Xultophy) und IGlarLixi (Suliqua)

Both forms of the peptide are indistinguishable in their ability to produce biological effects through GLP-1 receptors located in pancreatic cells [3], gastric glands [4] and in adipocytes [5], lung [6] and brain [7-10]

And with addiction, more than any other disease, the number of deaths averted captures just a piece of the devastating cascade of downstream consequences that tear apart families, communities, and entire countries

When you wake up, you're in a catabolic (breakdown) state